Peripheral Vascular Disease
A study to evaluate the study and effectiveness of the Ranger Paclitaxel drug coated balloon versus standard Balloon for Angioplasty of lesions in the superficial femoral and proximal popliteal arteries (SFA/PPA) in peripheral vascular disease.
Principal Investigator: Srini Potluri, MD
Locations: Baylor Scott & White The Heart Hospital – Plano
Sponsor: Boston Scientific
IRB Number: 016-258
Trial Status: Enrolling
Exclusions: Adults only
Note: studies requiring extended follow-up for products that were investigational, but have become commercially available since then are not considered investigational studies.
Change in Care: Duplex ultrasounds will be performed at each follow up visit as well as quality of life questionnaires and a 6 minute walk
Julie McCracken, CCRC469.814.4717Julie.McCracken@BSWHealth.org
Rachelle Winkle, RN469.814.4183Rachelle.Winkle@BSWHealth.org
A 3:1 Randomized Trial Comparing the Boston Scientific RANGER™ Paclitaxel Coated Balloon vs Standard Balloon Angioplasty for the Treatment of Superficial Fermoal Arteries (SFA) and Proximal Popliteal Arteries (PPA)
Get Detailed Information On Clinicaltrials.gov »
Physicians are members of the medical staff at one of Baylor Health Care System's subsidiary, community or affiliated medical centers and are neither employees nor agents of those medical centers, Baylor Scott & White The Heart Hospital – Plano or Baylor Health Care System.